1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Oman Pharmaceuticals and Healthcare Report Q3 2016

Oman Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 77 pages

Includes 3 FREE quarterly updates

BMI View: Oman's evolving demographic and epidemiological profile will act as key drivers of growthwithin the country's pharmaceuticals and healthcare markets over the coming years. We view Oman ashaving considerable growth potential, supported by an expanding private sector and the government'songoing commitment to advancing healthcare. The country's weak domestic manufacturing capabilities willensure Oman remains an import-driven market, particularly as the population favours those innovativemedicines sourced from abroad. Over the long term, Oman's population will benefit from more affordablehealthcare services as price unification becomes more standardised across the Gulf States.

Headline Expenditure Projections

- Pharmaceuticals: OMR242mn (USD628mn) in 2015 to OMR258mn (USD671mn) in 2016; 6.8% inlocal currency and US dollar terms. Forecast in line with Q216.

- Healthcare: OMR1.10bn (USD2.86bn) in 2015 to OMR1.15bn (USD3.00bn) in 2016; +4.9% in localcurrency terms, +5.0% in US dollar terms. Forecast in line with Q216.

Table Of Contents

Oman Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Oman 2014-2020) 7
SWOT 9
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Oman 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Oman 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Oman 2014-2020) 29
Industry Risk/Reward Index 30
Middle East and Africa Risk/Reward Index - Q3 2016 30
Oman Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 41
Intellectual Property Issues 42
Pricing Regime 43
Reimbursement Regime 45
Market Overview 46
Healthcare Sector 47
Table: Healthcare Resources (Oman 2010-2015) 49
Table: Healthcare Personnel (Oman 2010-2015) 49
Table: Healthcare Activity (Oman 2010-2015) 50
Research and Development 50
Clinical Trials 51
Epidemiology 52
Competitive Landscape 56
Research-Based Industry 56
Table: Multinational Market Activity 57
Generic Drugmakers 58
Pharmaceutical Distribution 59
Pharmaceutical Retail Sector 59
Company Profile 60
National Pharmaceutical Industries 60
Zynova/Oman Pharmaceutical Products Company 63
Demographic Forecast 66
Table: Population Headline Indicators (Oman 1990-2025) 67
Table: Key Population Ratios (Oman 1990-2025) 67
Table: Urban/Rural Population and Life Expectancy (Oman 1990-2025) 68
Table: Population By Age Group (Oman 1990-2025) 68
Table: Population By Age Group % (Oman 1990-2025) 69
Glossary 71
Methodology 73
Pharmaceutical Expenditure Forecast Model 73
Healthcare Expenditure Forecast Model 73
Notes On Methodology 74
Risk/Reward Index Methodology 75
Index Overview 76
Table: Pharmaceutical Risk/Reward Index Indicators 76
Indicator Weightings 77

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.